You are here

P&T October 2013

Features

Health Care & Law

State policies vary regarding the legal use of marijuana for medicinal purposes. Pharmacists, physicians, and P&T committee members must become familiar with the laws in their states before assuming that this controlled substance can be legally prescribed or dispensed to patients.

Part 2: Challenges Impeding Clinical Implementation

Many obstacles currently limit the ability to apply our knowledge of gene–drug associations in pharmacy practice. However, steps are gradually being taken toward the goal of incorporating genetic testing into routine patient care.

A Survey of Pharmacy Consultant Experiences Among Hospitals In the University HealthSystem Consortium

Respondents generally rated their experiences with consultants as positive. However, participants’ responses varied in terms of how much they felt that the consultants were helping their organizations to cut costs and increase revenue.

Meeting Highlights
Topics include drug therapies for venous thromboembolism, hypertension, plaque regression, and the prevention of stent thrombosis.

Departments

Medication Errors
Giving medications though enteral feeding tubes can be fraught with danger.
Prescription: Washington
More FDA regulation of HIT looms large.

FDA approvals, drug indications, and updates

Dolutegravir (Tivicay) for HIV-1 infection; topiramate extended release (Trokendi XR) for epilepsy; and ferric carboxymaltose (Injectafer) for iron-deficiency anemia

Drug Forecast
Recombinant relaxin (serelaxin), a breakthrough therapy for acute heart failure